USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa
Overview of the Orphan Diseases and Drugs Space in Sub-Saharan Africa
The other diseases of the Millennium Development Goal 6
RELEASE DATE
19-Apr-2012
19-Apr-2012
REGION
Africa
Africa
Deliverable Type
Market Research
Market Research
Research Code: M70B-01-00-00-00
SKU: HC01930-AF-MR_07036
$6,950.00
In stock
SKU
HC01930-AF-MR_07036
Research was carried out on the orphan disease and related drug space in Sub-Saharan Africa with emphasis on 5 countries, namely, Ghana, Nigeria, Uganda, Kenya and Tanzania. An analysis into the systems, treatment regimes and organisation and company involvement and their interrelations was carried out. Each country's status, with respect to these analyses results, was ascertained. Market dynamics, including challenges, drivers and restraints, were also identified along with potential involvement opportunities.
Overview of The Orphan Diseases and Drugs Space in Sub-Saharan Africa
- Introduction to The Orphan Drugs and Diseases Space in Sub-Saharan Africa
Overview of The Research Aims and Objectives
- Introduction to the Research Aim and Objectives
Overview of The Research Scope, Definitions and Exchange Rates
- Introduction to The Research Scope, Definitions and Exchange Rates
Overview of The Research Methodology
- Introduction to The Research Methodology
Overview of Orphan Drugs and Diseases in Sub-Saharan Africa
- An Introduction to Orphan Drugs and Diseases in Sub-Saharan Africa
Overview of Neglected Diseases in Sub-Saharan Africa
- Introduction to the Neglected Diseases in Sub-Saharan Africa
Overview of Orphan Drugs and Their Disrtibution Programs
- Introduction to Orphan Drugs and Their Distribution Programs
Overview of Ghana
- Introduction to Ghana
Overview of Nigeria
- Introduction to Nigeria
Overview of Uganda
- Introduction to Uganda
Overview of Kenya
- Introduction to Kenya
Overview of Tanzania
- Introduction to Tanzania
Conclusion Overview
- Introduction to Conclusions
Appendix Overview
- Introduction to the Appendix
Overview of The Orphan Disease and Drug Space in Sub-Saharan Africa
- Introduction to Frost & Sullivan
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research was carried out on the orphan disease and related drug space in Sub-Saharan Africa with emphasis on 5 countries, namely, Ghana, Nigeria, Uganda, Kenya and Tanzania. An analysis into the systems, treatment regimes and organisation and company involvement and their interrelations was carried out. Each country's status, with respect to these analyses results, was ascertained. Market dynamics, including challenges, drivers and restraints, were also identified along with potential involvement opportunities.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Author | Megan Van Den Berg |
| Industries | Healthcare |
| WIP Number | M70B-01-00-00-00 |
| Is Prebook | No |